LeafNLP Demos
Back to explore

Report #2875540

Received Dec 1, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
10 yrs
State
IA
Recovered
Unknown
Vaccinated
Nov 21, 2025
Onset
Nov 21, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (2)

Expired product administeredProduct administered to patient of inappropriate age

Symptom narrative

Expired dose; inappropriate age at vaccine administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 10-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (expiry date 19-NOV-2025) for prophylaxis. On 21-NOV-2025, the patient received Arexvy. On 21-NOV-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expired dose) and inappropriate age at vaccine administration (Verbatim: inappropriate age at vaccine administration). The outcome of the expired vaccine used and inappropriate age at vaccine administration were not applicable. Additional Information: GSK receipt date: 26-NOV-2025 The vaccine administration facility was the same as primary reporter. The batch number was not provided upon follow- up with the reporter.